Literature DB >> 11230591

Relation of two different subtypes of croup before age three to wheezing, atopy, and pulmonary function during childhood: a prospective study.

J A Castro-Rodríguez1, C J Holberg, W J Morgan, A L Wright, M Halonen, L M Taussig, F D Martinez.   

Abstract

OBJECTIVE: Some retrospective evidence suggests that children with a history of croup may be at increased risk of subsequently developing asthma, atopy, and diminished pulmonary function. The objective of this study was to determine the long-term outcome of croup (as diagnosed by a physician) in early life.
METHODS: Lower respiratory illnesses (LRIs) in the first 3 years of life were assessed in 884 children who were enrolled in a large longitudinal study of airway diseases at birth. Pulmonary function tests, markers of atopy, and wheezing episodes were studied at different ages between birth and 13 years.
RESULTS: Ten percent of children had croup with wheeze (Croup/Wheeze), 5% had croup without wheeze (Croup/No Wheeze), 36% had another LRI (Other LRI), and 48% had no LRI. Respiratory syncytial virus was more frequently isolated in children with Croup/Wheeze and Other LRI than in those with Croup/No Wheeze. There was no association between croup in early life and markers of atopy measured during the school years. Only children with Croup/Wheeze and with Other LRI had a significant risk of subsequent persistent wheeze later in life. Significantly lower levels of indices of intrapulmonary airway function were observed at ages <1 (before any LRI), 6, and 11 years in children with Croup/Wheeze and Other LRI compared with children with No LRI. Conversely, inspiratory resistance before any LRI episode was significantly higher in infants who later developed Croup/No Wheeze than in the other 3 groups.
CONCLUSIONS: We distinguish 2 manifestations of croup with and without wheezing. Children who present with croup may or may not be at increased risk of subsequent recurrent lower airway obstruction, depending on the initial lower airway involvement, and preillness and postillness abnormalities in lung function associated with this condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230591     DOI: 10.1542/peds.107.3.512

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Food allergy is associated with an increased risk of asthma.

Authors:  A Schroeder; R Kumar; J A Pongracic; C L Sullivan; D M Caruso; J Costello; K E Meyer; Y Vucic; R Gupta; J S Kim; R Fuleihan; X Wang
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

Review 2.  The asthma epidemic and our artificial habitats.

Authors:  Wasim Maziak
Journal:  BMC Pulm Med       Date:  2005-03-31       Impact factor: 3.317

3.  Lung Function in Wheezing Infants after Acute Lower Respiratory Tract Infection and Its Association with Respiratory Outcome.

Authors:  Yuan-Yuan Qi; Gao-Li Jiang; Li-Bo Wang; Cheng-Zhou Wan; Xiao-Bo Zhang; Li-Ling Qian
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

4.  Association of childhood croup and increased incidence of airway hyperreactivity in adulthood.

Authors:  Mohammadreza Modaresi; Ali Pourvali; Gholamreza Azizi; Reza Rezaee Taher; Tina Alinia; Mohsen Reisi
Journal:  J Educ Health Promot       Date:  2018-08-02

Review 5.  A multi-disciplinary approach to chronic cough in children.

Authors:  Shraddha S Mukerji; Naga Jaya Smitha Yenduri; Eric Chiou; Siby P Moonnumakal; Joshua R Bedwell
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-23

6.  CD14 gene variants and their importance for childhood croup, atopy, and asthma.

Authors:  Donna C Rennie; Chandima P Karunanayake; Yue Chen; Kazuko Nakagawa; Punam Pahwa; Ambikaipakan Senthilselvan; James A Dosman
Journal:  Dis Markers       Date:  2013-11-21       Impact factor: 3.434

7.  Association of croup with asthma in children: A cohort study.

Authors:  Sheng-Chieh Lin; Hui-Wen Lin; Bor-Luen Chiang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.